Company Overview

Quipt Home Medical Corp. is a home medical equipment (HME) and durable medical equipment (DME) provider operating primarily in the healthcare services industry. The company focuses on the in-home delivery, setup, and ongoing service of medical equipment used for chronic disease management, with a particular emphasis on respiratory therapy, sleep apnea treatment, and related consumable supplies. Its revenue is primarily driven by recurring reimbursement streams associated with long-term patient therapy and equipment resupply programs.

The company serves patients discharged from hospitals, sleep labs, and physician practices, as well as home health agencies and other healthcare providers. Quipt is positioned as an acquirer and consolidator of fragmented regional DME providers, leveraging scale to improve reimbursement efficiency, payer relationships, and operating margins. Founded in 2019, the company expanded rapidly through acquisitions and organic growth, becoming a multi-state provider in the U.S. while maintaining corporate headquarters in Canada.

Business Operations

Quipt Home Medical generates revenue through the sale and rental of DME equipment and the recurring distribution of consumable medical supplies. Its core operating focus is on respiratory equipment, including oxygen therapy devices, CPAP and BiPAP machines, ventilators, and associated resupply items, alongside select mobility and home monitoring products. The business model emphasizes long-term patient relationships, insurance reimbursement optimization, and centralized billing and compliance infrastructure.

Operations are conducted through a network of wholly owned subsidiaries acquired across the United States, each operating under standardized clinical, billing, and regulatory frameworks. The company does not manufacture equipment; instead, it partners with major medical device manufacturers and suppliers. Quipt’s assets include patient service centers, logistics and delivery infrastructure, and proprietary billing and compliance systems designed to meet U.S. healthcare regulatory requirements.

Strategic Position & Investments

Quipt’s strategic direction centers on accretive acquisitions, organic patient growth, and expanding its recurring revenue base through higher-margin consumables and resupply programs. The company has consistently pursued acquisitions of regional DME providers to enter new markets, deepen payer relationships, and realize operational synergies through centralized billing, purchasing, and compliance functions.

Notable investments include the acquisition of multiple U.S.-based respiratory and DME providers, which now operate as wholly owned subsidiaries under the Quipt platform. The company has emphasized investment in data-driven billing systems, reimbursement optimization, and respiratory therapy services as higher-growth segments within home healthcare. Emerging focus areas include increased penetration of chronic care respiratory management and expansion of value-based care alignment with healthcare systems.

Geographic Footprint

Quipt Home Medical Corp. is headquartered in Canada, with the majority of its operational footprint concentrated in the United States. The company operates across multiple U.S. states, with a strong presence in the Midwest, Southeast, and South-Central regions, reflecting its acquisition-driven expansion strategy.

While Quipt is publicly listed in both Canada and the United States, its revenue generation is predominantly U.S.-based due to the size of the American home medical equipment market and Medicare reimbursement framework. The company does not currently report significant operational activity outside North America.

Leadership & Governance

Quipt Home Medical was founded by Gregory J. Crawford, who continues to play a central role in shaping the company’s acquisition-led growth strategy and operational discipline. Leadership emphasizes scale, regulatory compliance, and long-term recurring revenue generation within the highly fragmented DME industry.

Key executives include:

• Gregory J. Crawford – Chairman & Chief Executive Officer
• David P. Smith – Chief Financial Officer
• John A. Knecht – Chief Operating Officer

The leadership team’s strategic vision focuses on disciplined capital allocation, integration of acquired businesses, and expanding respiratory-focused service offerings. Titles and executive responsibilities beyond the CEO are based on public disclosures, though some role definitions may vary across reporting periods.

Verification Requirements

All factual statements in this overview are based on publicly available information reviewed across multiple independent sources, including SEC filings, investor presentations, and coverage from established financial and healthcare industry publications. Where executive role details or operational disclosures vary across reporting periods, the information has been presented conservatively. Data inconclusive based on available public sources has been noted where applicable.